ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0658

Integrative Analysis of Cell-Specific Human Endogenous Retrovirus Expression and Host Gene Expression Identifies Associations with Clinical SLE Phenotypes

Zachary Cutts1, Sarah Patterson2, Lenka Maliskova1, Chun Ye2, Maria Dall'Era3, Jinoos Yazdany4, Lindsey Criswell5, Charles Langelier6, Marina Sirota7 and Cristina M Lanata8, 1University of California, San Francisco, San Francisco, 2University of California, San Francisco, San Francisco, CA, 3University of California, Division of Rheumatology, San Francisco, CA, 4UCSF, San Francisco, CA, 5National Human Genome Research Institute, NIH, Bethesda, MD, 6UCSF, San Francisco, 7UCSF, SF, 8NIH/NHGRI, Washington, DC

Meeting: ACR Convergence 2022

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Human endogenous retroviruses (HERVs) and long interspersed nuclear elements (LINEs) make up 5-8% and 21% of the human genome, respectively. Their expression may contribute to production of type I interferon and the generation of autoantibodies. The objective of this study was to detect HERVs and LINEs in 4 cell-types in SLE patients and characterize their relationship to host gene expression and SLE phenotypes.

Methods: Peripheral blood mononuclear cells were isolated from 120 deeply phenotyped SLE participants. Cells were sorted utilizing magnetic beads (CD14+ monocytes, B cells, CD4+ T cells, and NK cells) and STEM cell technologies for a total of 480 samples. Libraries were sequenced on a HiSeq4000 PE150. Trimmed fastq files were aligned to GRCh38 release 104 using default settings with STAR to generate alignment files. Alignment files were converted to gene counts using featureCounts. Raw counts from Telescope were normalized using DESeq2 and summed per patient; patients were then separated into tertiles based on the summed counts for HERVs and LINEs. DESeq2 was used to perform differential gene expression analysis using gene counts from featureCounts, comparing the third to the first tertile. Gene set enrichment analysis was performed using genes with adjusted p values < 0.05, ranking genes by log2FoldChange, and running WebGestalt. For clinical outcomes, outliers were identified and dropped per cell type and differential expression analysis was run using raw counts from Telescope with DESeq2 per cell type, adjusting for race, lane, sex, and immunosuppressant use at the time of blood draw. Outcomes studied included disease activity (SLEDAI score), autoantibody production (dsDNA, RNP, Sm), ACR renal criteria and disease severity (as defined by clinical clusters previously described in the same SLE participants)1.

Results: A total of 26,768 HERVs/LINEs were detected across the 480 samples. These were mostly cell-specific (Fig1). High HERVs/LINEs expression correlated with host gene transcription in a cell specific manner. Differentially enriched pathways with retroviral load include olfactory signaling pathway, regulation of IFNA signaling, and interferon alpha/beta signaling in CD14 cells; DNA repair and host response of HIV factors in CD4 cells; activation of HOX genes and antimicrobial peptides in CD19 cells; and regulation of complement cascade, neutrophil degranulation and several metabolic pathways in NK cells (Fig 2). Significant associations between HERVs/LINEs expression and clinical outcomes are summarized in Table 1. We found that CD19 cells had the most robust associations with disease severity, SLEDAI score, history of renal disease, and autoantibody production (FDR p< 0.05). Other findings included high HERVs/LINEs expression in NK cells in patient with severe disease, and in CD4 cells in patients with dsDNA production (FDR p< 0.05).

Conclusion: HERVs/LINEs expression is associated with host gene expression in relevant immune pathways in patients with SLE, in a cell specific manner. Further, we found a strong association between HERVs/LINEs expression and clinical outcomes, particularly in CD19 cells, in SLE patients.

Supporting image 1

PCA plot of HERVs and LINEs expression in 4 cell types of 120 SLE individuals

Supporting image 2

Pathways of differentially expressed genes associated with high HERVs/LINEs expression per cell type in 120 SLE patients

Supporting image 3

HERVs/LINEs expression associated with clinical outcomes, adjusted for sex, race and immunosuppressive medication use in 120 SLE participants


Disclosures: Z. Cutts, None; S. Patterson, Motto; L. Maliskova, None; C. Ye, None; M. Dall'Era, GlaxoSmithKline (GSK), AstraZeneca, Aurinia, BMS, Amgen; J. Yazdany, AstraZeneca, Gilead, Bristol-Myers Squibb(BMS), Aurinia, Astra Zeneca, Pfizer; L. Criswell, None; C. Langelier, None; M. Sirota, None; C. M Lanata, None.

To cite this abstract in AMA style:

Cutts Z, Patterson S, Maliskova L, Ye C, Dall'Era M, Yazdany J, Criswell L, Langelier C, Sirota M, M Lanata C. Integrative Analysis of Cell-Specific Human Endogenous Retrovirus Expression and Host Gene Expression Identifies Associations with Clinical SLE Phenotypes [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/integrative-analysis-of-cell-specific-human-endogenous-retrovirus-expression-and-host-gene-expression-identifies-associations-with-clinical-sle-phenotypes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrative-analysis-of-cell-specific-human-endogenous-retrovirus-expression-and-host-gene-expression-identifies-associations-with-clinical-sle-phenotypes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology